Shibao K et al [4] first demonstrated that YBX1 expression is elevated in CRC and positively correlates with DNA topoisomerase II α and proliferating cell nuclear antigen [PCNA] expression but not with multi-drug resistance gene [MDR1]. The gene discussed is YBX1; the disease is colorectal carcinoma.